@article{ref1,
title="Toward a typology of hallucinogen users in the United States",
journal="Drug and alcohol dependence",
year="2021",
author="Salas-Wright, Christopher P. and Hodges, James C. and Hai, Audrey Hang and Alsolami, Abdulaziz and Vaughn, Michael G.",
volume="229",
number="Pt B",
pages="e109139-e109139",
abstract="BACKGROUND: Roughly one in ten American adults have used hallucinogens, and emerging evidence suggests that the prevalence of use is increasing. However, our understanding of the degree to which individuals &quot;specialize&quot; in the use of a particular hallucinogen or are poly-hallucinogen users remains incomplete. <br><br>METHODS: This study examined data from 6381 individuals reporting past-year hallucinogen use in the 2016-2018 National Survey on Drug Use and Health. Logistic regression examined the association between the number of distinct hallucinogens used and psychosocial/behavioral risks, and latent class analysis (LCA) characterized subgroups of hallucinogen users. <br><br>RESULTS: The vast majority of hallucinogen users, roughly 70%, are not &quot;specialists&quot; who use only one hallucinogen type; rather, lifetime poly-hallucinogen use is the norm. Critically, however, we also see that important differences exist within the population of hallucinogen users-half (51%) could be classified as LSD-Mushroom-Ecstasy users only (this group was disproportionally comprised of youth), nearly one third (30%) were Poly-Hallucinogen users (this group was disproportionately male and non-Hispanic White), and smaller proportions were limited primarily to use of LSD-Mushrooms (6%; these individuals were almost exclusively ages 35 and older) or Ecstasy Only (12%; these individuals were mostly younger adults ages 18-34). <br><br>CONCLUSIONS: Findings provide a fresh contribution to our understanding of poly-hallucinogen use in a time in which local and state governmental leaders, and people across the country, weigh the benefits and drawbacks of legalizing specific hallucinogenic drugs.<p /> <p>Language: en</p>",
language="en",
issn="0376-8716",
doi="10.1016/j.drugalcdep.2021.109139",
url="http://dx.doi.org/10.1016/j.drugalcdep.2021.109139"
}